![](https://b2665405.smushcdn.com/2665405/wp-content/uploads/2023/03/c_45_1048_pediatric_trial.jpg?lossy=2&strip=1&webp=1)
This study is evaluating the safety and immune response generated by an investigational bivalent COVID-19 vaccine as a primary 3-dose series plus booster in healthy infants and children under 5 who have not previously been vaccinated for COVID-19.
This study is evaluating the safety and immune response generated by an investigational bivalent COVID-19 vaccine as a primary 3-dose series plus booster in healthy infants and children under 5 who have not previously been vaccinated for COVID-19.